Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-05-31
2005-05-31
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S359000, C514S367000, C514S394000, C544S283000, C544S106000, C548S121000, C548S146000, C548S180000, C548S310100, C548S165000, C548S182000, C548S316400
Reexamination Certificate
active
06900218
ABSTRACT:
Certain known and novel pyruvate derivatives are particularly active in restoring or preserving metabolic integrity in oxidatively competent cells that have been subjected to oxygen deprivation. These pyruvate-derived compounds include, but are not limited to oximes, amides, pyruvate analogues, modified pyruvate analogues, esters of pyruvate (e.g., polyol-pyruvate esters, pyruvate thioesters, glycerol-pyruvate esters and dihydroxyacetone-pyruvate esters). Such pyruvate derivatives (including single tautomers, single stereoisomers and mixtures of tautomers and/or stereoisomers, and the pharmaceutically acceptable salts thereof) are useful in the manufacture of pharmaceutical compositions for treating a number of conditions characterized by oxidative stress.
REFERENCES:
patent: 4137320 (1979-01-01), Tedeschi
patent: 4762848 (1988-08-01), Scheunemann et al.
patent: 4914206 (1990-04-01), Minamida et al.
patent: 5141946 (1992-08-01), Katano et al.
patent: 5189158 (1993-02-01), Feigelson et al.
patent: 5719147 (1998-02-01), Dorn et al.
patent: 5866604 (1999-02-01), Pellacini et al.
patent: 6057312 (2000-05-01), Cho et al.
patent: 6348617 (2002-02-01), Ushio et al.
patent: 288789 (1988-11-01), None
patent: 795554 (1997-09-01), None
patent: 2 076 803 (1981-12-01), None
patent: WO2001002373 (2001-01-01), None
patent: WO 01/25210 (2001-04-01), None
patent: WO 01/40206 (2001-06-01), None
patent: WO 02/074301 (2002-09-01), None
Labrou Journal of Protein Chemistry 18(7): 729-733, 1999.*
Capozzi et al., Tetrahedron Letters 38(28): 5041-5044, 1997.*
Sayed et al., Egyptian Journal Of Pharmaceutical Sciences 37(1-6): 295-302,1996.*
Labrou et al., Journal of Chromatography A 718(11): 35-44, 1995.*
Shahripour et al., Journal of Medicinal Chemistry 38(15): 2893-2905.*
Abdel-Rahman al., Pakistan Journal of Scientific and Industrial Research 35(3): 69-72, 1992.*
Lattrell et al., Justus Liebigs Annalen der Chemie 6: 921-922, 1974.*
Alper et al., Journal of Organic Chemistry 38(21) 3742-3744, 1973.*
Alper et al., Journal of Organic Chemistry 36910) 1352-1355, 1971.*
Haskell et al., Journal of Medicinal Chemistry 13(4): 697-704, 1970.*
Westphal, G. et al. (1976) “Reactions with Pyridinium Pyruvates”Pharamazie31(11):770-773. (abstract).
Iwamatsu, K. et al. (1983). “Synthesis and Biological Activity of 7,8-(2-Amino-2-Carboxy)-Ethylthioacetamido-7alpha-Methoxycephalosporin Derivatives”Journal of Antibiotics. 36(3):229-241.
Bedeschi, A. et al. (1982). “Synthesis and In Vitro Activity of Some 7-[2-Metholyimino-(Substitiuted Thio)Alkanoyl]Amino Cephalosporanic Acid Derivatives”Journal of Antibiotics. 35(6):712-720.
Cavero, M. et al. (2001). “Studies on the intermolecular free radical addition of thionitrites to alkenes: a convenient method of the preparation of alpha-tritylthio oximes and related derivatives”Tetrahedron Letters42:4377-4379.
Gilchrist, T.L. et al. (1987). “Reaction of Azoles with Ethyl Bromoopyruvate Oxime: Alkylation by Substitution and by Elimination-Addition”J. Chem. Soc. Perkin Trans.1(10):2235-2240.
Gilchrist, T. et al. (1979). “Ethyl 3-Bromo-2-hydroxyiminopropanoate, a Reagent for the Preparation of Ethyl Esters of alpha-Amino Acids”Journal of the Chemical Society, Chem. Comm.1089-1090.
Sidky, M.M. et al. (1972) “Mannich Bases of Glyoxylanilide 2-Oximes and their Effect on Photosyntetic Electron Transport”Z. Naturforssch.27b:797-799.
Andreichikov, Y.S. et al. (1977). “ Chemistry of oxalyl derivatives of methyl ketones. XVII. Synthesis and biological activity of the esters of arlylsulfonylpyruvic acids and their derivatives”Khimiko-Farmatsevticheskii Zhurnal11(10):85-89. (abstract).
Fridman, A.L. et al. (1977). “Reactions of aliphatic diazo compounds. XXX. Synthesis of 2-diazo-3-(arylsulfonlyl)propanoate”Zh. Organic Khim.13 (8):1589-1593. (abstract).
Andreichikov, Y.S. et al. (1977). “Chemistry of oxalyl derivatives of methyl ketones. VIII. Synthesis and properties of arylsulfonylpyroracemic acid esters”Zh. Organic Khim.13(10):2070-2074. (abstract).
Harash et al. (1973).J.Prakt. Chemincal.315:235-242 (abstract).
Eistert, B. et al. (1963)Justus Liebigs Ann. Chemical.666:97-112.
Rossi, S. et al. (1962).Gazz. Chim. Ital.92:1367-1378.
Janagani Satyanarayana
Miller Guy
Wang Bing
Balasubramanian Venkataraman
Foley & Lardner LLP
Galileo Pharmaceuticals, Inc.
LandOfFree
Pyruvate derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyruvate derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyruvate derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3424800